Global
Health
Funds
Investments to Improve and Save Lives
Access Bio joins Abbott as the second company with FDA authorization to distribute PCR, antigen and antibody tests for COVID-19.Access Bio joins Abbott as the
Alydia Health Completes Enrollment of its Pivotal PEARLE IDE Study in Women with Postpartum Hemorrhage The investigational Jada System is designed to treat abnormal postpartum
Milestone Reflects Merck’s Commitment to Accelerate SARS-CoV-2 Vaccine Program KENILWORTH, N.J.–(BUSINESS WIRE)– Merck (NYSE: MRK), known as MSD outside the United States and Canada, today
Global Health Investment Fund Portfolio Addressing COVID-19 Pandemic The rapid spread of COVID-19 across the globe has underscored the need for an equally rapid response,
Dr. Curt LaBelle has been investing in healthcare companies for over 18 years, and now serves as the Managing Partner of the Global Health Investment Fund
Wharton Business Radio – Dollars and Change, May 10, 2018 [Curt LaBelle appeared on Wharton Business Radio to discuss impact investing and global health challenges]
ImpactAlpha – After a dozen deals, Global Health Investment Fund has overcome a rocky start, October 10, 2018 [The Global Health Investment Fund profiled, Curt
The Sydney Morning Herald – Australian not-for-profit wins unprecedented approval for blindness drug, July 22, 2018 [The Global Health Investment Fund was featured in this